Leader in traumatic brain injury management completes first client intake to receive groundbreaking treatment program for gait and balance symptoms from previous mild-to-moderate traumatic brain injuries (mTBI)
MONTREAL, QC | March 4, 2019 – Heuro Canada Inc., a top provider of innovative neurological health solutions, announces the first client has completed intake to begin the revolutionary Heuro Program featuring the non-invasive Portable Neuromodulation Stimulator (PoNS™) Treatment at Neurotherapy Montreal, Heuro’s first clinic to offer the Health-Canada approved treatment in Canada.
Neurotherapy Montreal is the first licensed clinic in Canada to
offer powerful therapeutic treatment designed to help individuals experiencing chronic balance deficits. Combining physical therapy with Helius Medical Technologies’ PoNS™ neurotechnology, the Heuro Program allows clients to manage and treat neurological symptoms associated with mild-to-moderate traumatic brain injuries over a 14-week period.
Rudi van den Broek, Managing Director of Heuro Canada, says “the first client to start the Heuro Program featuring the PoNS™ treatment is a significant milestone for Heuro, which aims to improve the quality of life for Canadians experiencing gait and balance symptoms from previous mild-to-moderate traumatic brain injuries.”
Nicole Strachan, clinical lead for Heuro Canada, says the treatment plan will focus on the personal rehabilitation of each client.
“Although it is a set program, each therapeutic plan is highly individualized to the needs of the client,” she says, “making it possible for Canadians to reach their personal goals of recovery and aim to improve their overall wellbeing.”
The PoNS™ Device is the first patented non-invasive means for delivering neurostimulation through the tongue and is designed to amplify the brain’s powerful ability to heal itself. The neurotechnology offers a transformative treatment experience with a high success rate.
Neurotherapy Montreal applies existing rehabilitation and recovery training procedures in conjunction with the latest neuromodulation and neuroscience technologies. The clinic helps individuals restore their livelihood and overcome neurological symptoms from previous mild-to-moderate traumatic brain injuries.
Heuro Canada is continuing to deploy the Heuro Program featuring the PoNS™ Treatment in licensed clinics across Canada. With plans to open subsequent clinics in major urban areas, the company aims to improve the quality of life for Canadians experiencing persistent deficiencies, such as gait and balance, from past mild-to-moderate brain injuries.
ABOUT HEURO CANADA INC.
Heuro Canada Inc. is a leading provider of innovative and transformative neurological health assessment and treatment technologies and solutions. With few viable therapeutic options currently available for managing and treating the neurological symptoms associated with mild-to-moderate traumatic brain injuries, the Heuro Program featuring the PoNS™ treatment program helps individuals restore their livelihood and overcome persistent gait and balance deficits from past mild-to-moderate traumatic brain injuries. Heuro Canada’s Surrey Neuroplasticity Clinic is Western Canada’s first clinic and the second clinic in Canada offering the Helius Medical Technology PoNS™ therapy.
ABOUT THE HEURO PROGRAM FEATURING PoNS™ TREATMENT The Portable Neuromodulation Stimulator (PoNS™) by U.S.-based Helius Medical Technologies, is a Class II Medical Device cleared for commercial distribution in Canada and an investigational, non-invasive, medical device currently under review by the United States Food and Drug Administration for clearance to improve balance in patients following a mild-to-moderate traumatic brain injury (mTBI) when combined with targeted physical therapy. PoNS™ Treatment is the first and only tongue-delivered neuromodulation treatment being developed to combine stimulation of cranial nerves with physical and cognitive therapy to restore lost neurological function.
For media inquiries, please contact: